Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Jun 22;6(6):CD012675.
doi: 10.1002/14651858.CD012675.pub2.

Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults

Melissa J Palmer  1 , Sharmani Barnard, Pablo Perel, Caroline Free
Affiliations
Meta-Analysis

Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults

Melissa J Palmer et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: Cardiovascular disease (CVD) is a major cause of disability and mortality globally. Premature fatal and non-fatal CVD is considered to be largely preventable through the control of risk factors via lifestyle modifications and preventive medication. Lipid-lowering and antihypertensive drug therapies for primary prevention are cost-effective in reducing CVD morbidity and mortality among high-risk people and are recommended by international guidelines. However, adherence to medication prescribed for the prevention of CVD can be poor. Approximately 9% of CVD cases in the EU are attributed to poor adherence to vascular medications. Low-cost, scalable interventions to improve adherence to medications for the primary prevention of CVD have potential to reduce morbidity, mortality and healthcare costs associated with CVD.

Objectives: To establish the effectiveness of interventions delivered by mobile phone to improve adherence to medication prescribed for the primary prevention of CVD in adults.

Search methods: We searched CENTRAL, MEDLINE, Embase, and two other databases on 21 June 2017 and two clinical trial registries on 14 July 2017. We searched reference lists of relevant papers. We applied no language or date restrictions.

Selection criteria: We included randomised controlled trials investigating interventions delivered wholly or partly by mobile phones to improve adherence to cardiovascular medications prescribed for the primary prevention of CVD. We only included trials with a minimum of one-year follow-up in order that the outcome measures related to longer-term, sustained medication adherence behaviours and outcomes. Eligible comparators were usual care or control groups receiving no mobile phone-delivered component of the intervention.

Data collection and analysis: We used standard methodological procedures recommended by Cochrane. We contacted study authors for disaggregated data when trials included a subset of eligible participants.

Main results: We included four trials with 2429 randomised participants. Participants were recruited from community-based primary care or outpatient clinics in high-income (Canada, Spain) and upper- to middle-income countries (South Africa, China). The interventions received varied widely; one trial evaluated an intervention focused on blood pressure medication adherence delivered solely through short messaging service (SMS), and one intervention involved blood pressure monitoring combined with feedback delivered via smartphone. Two trials involved interventions which targeted a combination of lifestyle modifications, alongside CVD medication adherence, one of which was delivered through text messages, written information pamphlets and self-completion cards for participants, and the other through a multi-component intervention comprising of text messages, a computerised CVD risk evaluation and face-to-face counselling. Due to heterogeneity in the nature and delivery of the interventions, we did not conduct a meta-analysis, and therefore reported results narratively.We judged the body of evidence for the effect of mobile phone-based interventions on objective outcomes (blood pressure and cholesterol) of low quality due to all included trials being at high risk of bias, and inconsistency in outcome effects. Of two trials targeting medication adherence alongside other lifestyle modifications, one reported a small beneficial intervention effect in reducing low-density lipoprotein cholesterol (mean difference (MD) -9.2 mg/dL, 95% confidence interval (CI) -17.70 to -0.70; 304 participants), and the other found no benefit (MD 0.77 mg/dL, 95% CI -4.64 to 6.18; 589 participants). One trial (1372 participants) of a text messaging-based intervention targeting adherence showed a small reduction in systolic blood pressure (SBP) for the intervention arm which delivered information-only text messages (MD -2.2 mmHg, 95% CI -4.4 to -0.04), but uncertain evidence of benefit for the second intervention arm that provided additional interactivity (MD -1.6 mmHg, 95% CI -3.7 to 0.5). One study examined the effect of blood pressure monitoring combined with smartphone messaging, and reported moderate intervention benefits on SBP and diastolic blood pressure (DBP) (SBP: MD -7.10 mmHg, 95% CI -11.61 to -2.59; DBP: -3.90 mmHg, 95% CI -6.45 to -1.35; 105 participants). There was mixed evidence from trials targeting medication adherence alongside lifestyle advice using multi-component interventions. One trial found large benefits for SBP and DBP (SBP: MD -12.45 mmHg, 95% CI -15.02 to -9.88; DBP: MD -12.23 mmHg, 95% CI -14.03 to -10.43; 589 participants), whereas the other trial demonstrated no beneficial effects on SBP or DBP (SBP: MD 0.83 mmHg, 95% CI -2.67 to 4.33; DBP: MD 1.64 mmHg, 95% CI -0.55 to 3.83; 304 participants).Two trials reported on adverse events and provided low-quality evidence that the interventions did not cause harm. One study provided low-quality evidence that there was no intervention effect on reported satisfaction with treatment.Two trials were conducted in high-income countries, and two in upper- to middle-income countries. The interventions evaluated employed between three and 16 behaviour change techniques according to coding using Michie's taxonomic method. Two trials evaluated interventions that involved potential users in their development.

Authors' conclusions: There is low-quality evidence relating to the effects of mobile phone-delivered interventions to increase adherence to medication prescribed for the primary prevention of CVD; some trials reported small benefits while others found no effect. There is low-quality evidence that these interventions do not result in harm. On the basis of this review, there is currently uncertainty around the effectiveness of these interventions. We identified six ongoing trials being conducted in a range of contexts including low-income settings with potential to generate more precise estimates of the effect of primary prevention medication adherence interventions delivered by mobile phone.

PubMed Disclaimer

Conflict of interest statement

MP: none known.

SB: none known.

PP: is the principal investigator for a study developing and piloting an mHealth intervention to increase adherence for cardiovascular secondary prevention interventions.

CF: we have developed an intervention delivered by text message designed to increase adherence to medication to prevent cardiovascular disease. We are likely to apply for funding for a randomised controlled trial to evaluate its effects.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Bobrow 2016 {published and unpublished data}
    1. Bobrow K, Brennan T, Springer D, Levitt NS, Rayner B, Namane M, et al. Efficacy of a text messaging (SMS) based intervention for adults with hypertension: protocol for the StAR (SMS Text‐message Adherence suppoRt trial) randomised controlled trial. BMC Public Health 2014;14:28. [DOI: ] - PMC - PubMed
    1. Bobrow K, Farmer AJ, Springer D, Shanyinde M, Yu LM, Brennan T, et al. Mobile phone text messages to support treatment adherence in adults with high blood pressure (SMS‐Text Adherence Support [StAR]): a single‐blind, randomized trial. Circulation 2016;133(6):592‐600. [DOI: ] - PMC - PubMed
    1. Galal U. Efficacy of a text messaging (SMS) based intervention for adults with hypertension: the *StAR (SMS Text‐message AdheRence Support) randomised controlled trial (unpublished data: results of cardiology history at screening) [personal communication]. Email to: M Palmer (LSHTM, London, UK) 19 April 2018.
    1. NCT02019823. Effectiveness of SMS‐text message support for patients with hypertension to improve blood pressure (*StAR). clinicaltrials.gov/ct2/show/NCT02019823 Date first received: 24 December 2013.
Liu 2015 {published data only (unpublished sought but not used)}
    1. ChiCTR‐TRC‐13003831. Study of community‐based prevention and control pattern on hypertension and diabetes for adults in Guanddong Province. www.chictr.org.cn/hvshowproject.aspx?id=7953 Date last refreshed on: 21 October 2013.
    1. Liu Z, Chen S, Zhang G, Lin A. Mobile phone‐based lifestyle intervention for reducing overall cardiovascular disease risk in Guangzhou, China: a pilot study. International Journal of Environmental Research & Public Health 2015;12(12):15993‐6004. [DOI: ] - PMC - PubMed
Logan 2012 {published data only (unpublished sought but not used)}
    1. Logan AG, Irvine MJ, McIsaac WJ, Tisler A, Rossos PG, Easty A, et al. Effect of home blood pressure telemonitoring with self‐care support on uncontrolled systolic hypertension in diabetics. Hypertension 2012;60(1):51‐7. [DOI: ] - PubMed
    1. NCT00717665. Self‐monitoring of blood pressure in primary care. clinicaltrials.gov/ct2/show/NCT00717665 Date first received: 17 July 2008.
Parraga‐Martinez 2017 {published data only (unpublished sought but not used)}
    1. NCT02314663. Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia (EFESCOM). clinicaltrials.gov/ct2/show/NCT02314663 Date first received: 11 December 2014.
    1. Parraga‐Martinez I, Rabanales‐Sotos J, Lago‐Deibe F, Tellez‐Lapeira JM, Escobar‐Rabadan F, Villena‐Ferrer A, et al. Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial. BMC Cardiovascular Disorders 2015;15:8. [DOI: ] - PMC - PubMed
    1. Párraga‐Martínez I, Escobar‐Rabadán F, Rabanales‐Sotos J, Lago‐Deibe F, Téllez‐Lapeira JM, Villena‐Ferrer A, et al. Efficacy of a combined strategy to improve low‐density lipoprotein cholesterol control among patients with hypercholesterolemia: a randomized clinical trial [Eficacia de una estrategia combinada para mejorar el control del colesterol unido a lipoproteínas de baja densidad en pacientes con hipercolesterolemia. Ensayo clínico aleatorizado]. Revista Española de Cardiología 2018;71(1):33‐41. - PubMed

References to studies excluded from this review

Bosworth 2007 {published data only}
    1. Bosworth HB, Olsen MK, McCant F, Harrelson M, Gentry P, Rose C, et al. Hypertension Intervention Nurse Telemedicine Study (HINTS): testing a multifactorial tailored behavioral/educational and a medication management intervention for blood pressure control. American Heart Journal 2007;153(6):918‐24. [DOI: 10.1016/j.ahj.2007.03.004] - DOI - PubMed
    1. Maciejewski ML, Bosworth HB, Olsen MK, Smith VA, Edelman D, Powers BJ, et al. Do the benefits of participation in a hypertension self‐management trial persist after patients resume usual care?. Circulation. Cardiovascular Quality and Outcomes 2014;7(2):269‐75. [DOI: 10.1161/CIRCOUTCOMES.113.000309] - DOI - PubMed
    1. Wang V, Smith VA, Bosworth HB, Oddone EZ, Olsen MK, McCant F, et al. Economic evaluation of telephone self‐management interventions for blood pressure control. American Heart Journal 2012;163(6):980‐6. [DOI: 10.1016/j.ahj.2012.03.016] - DOI - PubMed
Bove 2011 {published data only}
    1. Bove AA, Santamore WP, Homko C, Kashem A, Cross R, McConnell TR, et al. Reducing cardiovascular disease risk in medically underserved urban and rural communities. American Heart Journal 2011;16(2):351‐9. [DOI: 10.1016/j.ahj.2010.11.008] - DOI - PubMed
Broekhuizen 2010 {published data only}
    1. Broekhuizen K, Poppel MN, Koppes LL, Brug J, Mechelen W. A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with familial hypercholesterolemia (FH): design of the PRO‐FIT randomised controlled trial. BMC Public Health 2010;10:69. [DOI: ] - PMC - PubMed
Derose 2013 {published data only}
    1. Derose SF, Green K, Marrett E, Tunceli K, Cheetham TC, Chiu VY, et al. Automated outreach to increase primary adherence to cholesterol‐lowering medications. JAMA Internal Medicine 2013;173(1):38‐43. [DOI: 10.1001/2013.jamainternmed.717] - DOI - PubMed
Finkelstein 2009 {published data only}
    1. Finkelstein J, Cha E. Hypertension telemanagement in blacks. Circulation. Cardiovascular Quality and Outcomes 2009;2(3):272‐8. [DOI: 10.1161/CIRCOUTCOMES.109.849968] - DOI - PMC - PubMed
Fischer 2014 {published data only}
    1. Fischer MA, Choudhry NK, Bykov K, Brill G, Bopp G, Wurst AM, et al. Pharmacy‐based interventions to reduce primary medication nonadherence to cardiovascular medications. Medical Care 2014;52(12):1050‐4. [DOI: 10.1097/MLR.0000000000000247] - DOI - PubMed
Gerin 2007 {published data only}
    1. Gerin W, Tobin JN, Schwartz JE, Chaplin W, Rieckmann N, Davidson KW, et al. The medication Adherence and Blood Pressure Control (ABC) trial: a multi‐site randomized controlled trial in a hypertensive, multi‐cultural, economically disadvantaged population. Contemporary Clinical Trials 2007;28(4):459‐71. [DOI: 10.1016/j.cct.2007.01.003] - DOI - PubMed
Golshahi 2015 {published data only}
    1. Golshahi J, Ahmadzadeh H, Sadeghi M, Mohammadifard N, Pourmoghaddas A. Effect of self‐care education on lifestyle modification, medication adherence and blood pressure in hypertensive adults: randomized controlled clinical trial. Advanced Biomedical Research 2015;4:204. [DOI: 10.4103/2277-9175.166140] - DOI - PMC - PubMed
Johnson 2000 {published data only}
    1. Johnson BF, Hamilton G, Fink J, Lucey G, Bennet N, Lew R. A design for testing interventions to improve adherence within a hypertension clinical trial. Controlled clinical trials 2000;21(1):62‐72. [DOI: ] - PubMed
Kooy 2013 {published data only}
    1. Kooy MJ, Wijk BL, Heerdink ER, Boer A, Bouvy ML. Does the use of an electronic reminder device with or without counseling improve adherence to lipid‐lowering treatment? The results of a randomized controlled trial. Frontiers in Pharmacology 2013;4:69. [DOI: 10.3389/fphar.2013.00069] - DOI - PMC - PubMed
Margolis 2012 {published data only}
    1. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. Journal of the American Medical Association 2013;310(1):46‐56. [DOI: 10.1001/jama.2013.6549.] - DOI - PMC - PubMed
    1. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Maciosek MV, Nyboer RA, et al. A successful multifaceted trial to improve hypertension control in primary care: why did it work?. Journal of General Internal Medicine 2015;30(11):1665‐72. [DOI: 10.1007/s11606-015-3355-x] - DOI - PMC - PubMed
    1. Margolis KL, Kerby TJ, Asche SE, Bergdall AR, Maciosek MV, O'Connor PJ, et al. Design and rationale for home blood pressure telemonitoring and case management to control hypertension (HyperLink): a cluster randomized trial. Contemporary Clinical Trials 2012;33(4):794‐803. [DOI: 10.1016/j.cct.2012.03.014] - DOI - PMC - PubMed
McGillicuddy 2015 {published data only}
    1. McGillicuddy JW, Taber DJ, Mueller M, Patel S, Baliga PK, Chavin KD, et al. Sustainability of improvements in medication adherence through a mobile health intervention. Progress in Transplantation 2015;25(3):217‐23. [DOI: 10.7182/pit2015975] - DOI - PMC - PubMed
McManus 2010 {published data only}
    1. Bray EP, Jones MI, Banting M, Greenfield S, Hobbs FD, Little P, et al. Performance and persistence of a blood pressure self‐management intervention: telemonitoring and self‐management in hypertension (TASMINH2) trial. Journal of Human Hypertension 2015;29(7):436‐41. [DOI: 10.1038/jhh.2014.108] - DOI - PubMed
    1. Kaambwa B, Bryan S, Jowett S, Mant J, Bray EP, Hobbs FD, et al. Telemonitoring and self‐management in the control of hypertension (TASMINH2): a cost‐effectiveness analysis. European Journal of Preventive Cardiology 2014;21(12):1517‐30. [DOI: 10.1177/2047487313501886] - DOI - PubMed
    1. Kaambwa B, Bryan S, Mant J, Bray EP, Holder R, Jones M, et al. Randomised controlled trial of telemonitoring and self management in the control of hypertension: telemonitoring and self management in hypertension (TASMINH2): economic analysis. Journal of Hypertension 2010;28:e281‐2. [DOI: 10.1097/01.hjh.0000379032.42848.de] - DOI - PubMed
    1. McManus RJ, Bray EP, Mant J, Holder R, Greenfield S, Bryan S, et al. Protocol for a randomised controlled trial of telemonitoring and self‐management in the control of hypertension: telemonitoring and self‐management in hypertension. BMC Cardiovascular Disorders 2009;9:6. [DOI: 10.1186/1471-2261-9-6] - DOI - PMC - PubMed
    1. McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self‐management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet 2010;376(9736):163‐72. [DOI: ] - PubMed
Neafsey 2011 {published data only}
    1. Neafsey PJ, M'lan CE, Ge M, Walsh SJ, Lin CA, Anderson E. Reducing adverse self‐medication behaviors in older adults with hypertension: results of an e‐health clinical efficacy trial. Ageing International 2011;36(2):159‐91. [DOI: 10.1007/s12126-010-9085-9] - DOI - PMC - PubMed
O'Connor 2014 {published data only}
    1. O'Connor PJ, Schmittdiel JA, Pathak RD, Harris RI, Newton KM, Ohnsorg KA, et al. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes Care 2014;37(12):3317‐24. [DOI: 10.2337/dc14-0596] - DOI - PMC - PubMed
Olorun 2014 {published data only}
    1. Olorun OJ, Afolabi MO, Oyebisi TO, Ogunsina AO, Akintomide AO, Adebayo RA. Exploring medicine information needs of hypertensive patients using short message service. British Journal of Medicine & Medical Research 2014;4(34):5368‐80.
Parati 2013 {published data only}
    1. Parati G, Omboni S, Compare A, Grossi E, Callus E, Venco A, et al. Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study). Trials 2013;14:22. [DOI: 10.1186/1745-6215-14-22] - DOI - PMC - PubMed
Richard 2016 {published data only}
    1. Richard E, Jongstra S, Soininen H, Brayne C, Moll van Charante EP, Meiller Y, et al. Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment. BMJ Open 2016;6(6):e010806. [DOI: 10.1136/bmjopen-2015-010806] - DOI - PMC - PubMed
Salisbury 2016 {published data only}
    1. Salisbury C, O'Cathain A, Thomas C, Edwards L, Gaunt D, Dixon P, et al. Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial. BMJ 2016;353:i2647. [DOI: 10.1136/bmj.i2647] - DOI - PMC - PubMed
    1. Thomas CL, Man MS, O'Cathain A, Hollinghurst S, Large S, Edwards L, et al. Effectiveness and cost‐effectiveness of a telehealth intervention to support the management of long‐term conditions: study protocol for two linked randomized controlled trials. Trials 2014;24(15):36. [DOI: 10.1186/1745-6215-15-36] - DOI - PMC - PubMed
Vollmer 2014 {published data only}
    1. Vollmer WM, Owen‐Smith AA, Tom JO, Laws R, Ditmer DG, Smith DH, et al. Improving adherence to cardiovascular disease medications with information technology. American Journal of Managed Care 2014;20(11 Spec No. 17):SP502‐10. - PMC - PubMed
Wakefield 2011 {published data only}
    1. Wakefield BJ, Holman JE, Ray A, Scherubel M, Adams MR, Hillis SL, et al. Effectiveness of home telehealth in comorbid diabetes and hypertension: a randomized, controlled trial. Telemedicine and e‐Health 2011;17(4):254‐61. [DOI: 10.1089/tmj.2010.0176] - DOI - PubMed
Wald 2014 {published data only}
    1. Wald DS, Bestwick JP, Raiman L, Brendell R, Wald NJ. Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial). PloS One 2014;9(12):e114268. [DOI: 10.1371/journal.pone.0114268] - DOI - PMC - PubMed
Warren 2012 {published data only}
    1. Warren J, Kennelly J, Warren D, Elley CR, Wai KC, Manukia M, et al. Using the general practice EMR for improving blood pressure medication adherence. Studies in Health Technology and Informatics 2012;178:228‐34. [DOI: 10.3233/978-1-61499-078-9-228] - DOI - PubMed

References to ongoing studies

Choudhry 2016 {published data only}
    1. Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Khan NF, Lee M, et al. Rationale and design of the Study of a Tele‐pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): a cluster‐randomized pragmatic trial. American Heart Journal 2016;180:90‐7. [DOI: ] - PMC - PubMed
    1. NCT02512276. Tele‐Pharmacy Intervention to Improve Treatment Adherence (STIC2IT). clinicaltrials.gov/ct2/show/NCT02512276 Date first received: 30 July 2015.
Franssen 2017 {published data only}
    1. Franssen M, Farmer A, Grant S, Greenfield S, Heneghan C, Hobbs R, et al. Telemonitoring and/or self‐monitoring of blood pressure in hypertension (TASMINH4): protocol for a randomised controlled trial. BMC Cardiovascular Disorders 2017;17(1):58. [DOI: ] - PMC - PubMed
Gulayin 2017 {published data only}
    1. Gulayin P, Irazola V, Lozada A, Chaparro M, Santero M, Gutierrez L, et al. Educational intervention to improve effectiveness in treatment and control of patients with high cardiovascular risk in low‐resource settings in Argentina: study protocol of a cluster randomised controlled trial. BMJ Open 2017;7(1):e014420. [DOI: ] - PMC - PubMed
Jha 2017 {published data only}
    1. Jha D, Gupta P, Ajay VS, Jindal D, Perel P, Prieto‐Merino D, et al. Protocol for the mWellcare trial: a multicentre, cluster randomised, 12‐month, controlled trial to compare the effectiveness of mWellcare, an mHealth system for an integrated management of patients with hypertension and diabetes, versus enhanced usual care in India. BMJ Open 2017;7(8):e014851. [DOI: 10.1136/bmjopen-2016-014851] - DOI - PMC - PubMed
    1. NCT02480062. mWELLCARE: an integrated mHealth system for the prevention and care of chronic disease (mWELLCARE). clinicaltrials.gov/ct2/show/NCT02480062 Date first received: 24 June 2015.
Redfern 2014 {published data only}
    1. Redfern J, Usherwood T, Harris MF, Rodgers A, Hayman N, Panaretto K, et al. A randomised controlled trial of a consumer‐focused e‐health strategy for cardiovascular risk management in primary care: the CONsumer Navigation of Electronic Cardiovascular Tools (CONNECT) study protocol. BMJ Open 2014;4(2):e004523. [DOI: ] - PMC - PubMed
Xu 2017 {published data only}
    1. Xu L, Fang W, Zhu F, Zhang H, Liu K. A coordinated PCP‐Cardiologist Telemedicine Model (PCTM) in China's community hypertension care: study protocol for a randomized controlled trial. Trials 2017;18(1):236. [DOI: 10.1186/s13063-017-1970-z] - DOI - PMC - PubMed

Additional references

Adler 2017
    1. Adler AJ, Martin N, Mariani J, Tajer CD, Serrano NC, Owolabi OO, et al. Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2017, Issue 4. [DOI: 10.1002/14651858.CD011851.pub2] - DOI - PMC - PubMed
Anglada‐Martinez 2015
    1. Anglada‐Martinez H, Riu‐Viladoms G, Martin‐Conde M, Rovira‐Illamola M, Sotoca‐Momblona JM, Codina‐Jane C. Does mHealth increase adherence to medication? Results of a systematic review. International Journal of Clinical Practice 2015;69(1):9‐32. - PubMed
Bobrow 2014
    1. Bobrow K, Brennan T, Springer D, Levitt NS, Rayner B, Namane M, et al. Efficacy of a text messaging (SMS) based intervention for adults with hypertension: protocol for the StAR (SMS Text‐message Adherence suppoRt trial) randomised controlled trial. BMC Public Health 2014;14:28. [DOI: 10.1186/1471-2458-14-28] - DOI - PMC - PubMed
Caird 2014
    1. Caird JK, Johnston KA, Willness CR, Asbridge M, Steel P. A meta‐analysis of the effects of texting on driving. Accident Analysis & Prevention 2014;71:311‐8. - PubMed
Carrasco 2008
    1. Carrasco MP, Salvador CH, Sagredo PG, Márquez‐Montes J, González de Mingo MA, Fragua JA, et al. Impact of patient‐general practitioner short‐messages‐based interaction on the control of hypertension in a follow‐up service for low‐to‐medium risk hypertensive patients: a randomized controlled trial. IEEE Transactions on Information Technology in Biomedicine 2008;12(6):780‐91. [DOI: 10.1109/TITB.2008.926429] - DOI - PubMed
Chowdhury 2013
    1. Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, et al. Adherence to cardiovascular therapy: a meta‐analysis of prevalence and clinical consequences. European Heart Journal 2013;34(38):2940‐8. - PubMed
Collins 1990
    1. Collins R, Peto R, MacMahon S, Godwin J, Qizilbash N, Collins R, et al. Blood pressure, stroke, and coronary heart disease: part 2, short‐term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335(8693):827‐38. - PubMed
CTT 2012
    1. Cholesterol Treatment Trialists (CTT) Collaboration. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta‐analysis of individual data from 27 randomised trials. Lancet 2012;380(9841):581‐90. [DOI: ] - PMC - PubMed
da Costa 2012
    1. Costa TM, Barbosa BJ, Gomes e Costa DA, Sigulem D, Fatima Marin H, Filho AC, et al. Results of a randomized controlled trial to assess the effects of a mobile SMS‐based intervention on treatment adherence in HIV/AIDS‐infected Brazilian women and impressions and satisfaction with respect to incoming messages. International Journal of Medical Informatics 2012;81(4):257‐69. [DOI: 10.1016/j.ijmedinf.2011.10.002] - DOI - PMC - PubMed
DiMatteo 2004
    1. DiMatteo MR. Social support and patient adherence to medical treatment: a meta‐analysis. Health Psychology 2004;23(4):207‐18. [DOI: 10.1037/0278-6133.23.2.207] - DOI - PubMed
Douglas 2013
    1. Douglas N, Free C. 'Someone batting in my corner': experiences of smoking‐cessation support via text message. British Journal of General Practice 2013;63(616):e768‐76. - PMC - PubMed
Farmer 2016
    1. Farmer AJ, McSharry J, Rowbotham S, McGowan L, Ricci‐Cabello I, French DP. Effects of interventions promoting monitoring of medication use and brief messaging on medication adherence for people with type 2 diabetes: a systematic review of randomized trials. Diabetic Medicine 2016;33(5):565‐79. [DOI: 10.1111/dme.12987] - DOI - PubMed
Free 2016
    1. Free C, McCarthy O, French RS, Wellings K, Michie S, Roberts I, et al. Can text messages increase safer sex behaviours in young people? Intervention development and pilot randomised controlled trial. Health Technology Assessment (Winchester, England) 2016;20(57):1‐82. - PMC - PubMed
GRADEpro GTD 2015 [Computer program]
    1. McMaster University (developed by Evidence Prime). GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.
Guerriero 2013
    1. Guerriero C, Cairns J, Roberts I, Rodgers A, Whittaker R, Free C. The cost‐effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. European Journal of Health Economics 2013;14(5):789‐97. [DOI: 10.1007/s10198-012-0424-5] - DOI - PMC - PubMed
Higgins 2011
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
ICT 2016
    1. ICT. Key ICT indicators for developed and developing countries and the world, 2016. www.itu.int/en/ITU‐D/Statistics/Pages/facts/default.aspx (accessed 6 October 2016).
Julius 2009
    1. Julius RJ, Novitsky MA Jr, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. Journal of Psychiatric Practice 2009;15(1):34‐44. [DOI: 10.1097/01.pra.0000344917.43780.77] - DOI - PubMed
Kardas 2013
    1. Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Frontiers in Pharmacology 2013;4(91):eCollection. [DOI: 10.3389/fphar.2013.00091] - DOI - PMC - PubMed
Lavikainen 2016
    1. Lavikainen P, Helin‐Salmivaara A, Eerola M, Fang G, Hartikainen J, Huupponen R, et al. Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time dependent confounding affected by previous adherence. BMJ Open 2016;6(6):e011306. [DOI: 10.1136/bmjopen-2016-011306] - DOI - PMC - PubMed
Lefebvre 2011
    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Lester 2010
    1. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2010;376(9755):1838‐45. [DOI: 10.1016/S0140-6736(10)61997-6] - DOI - PubMed
Liberati 2009
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009;6(7):e1000100. - PMC - PubMed
Lim 2011
    1. Lim S, Kang SM, Shin H, Lee HJ, Yoon JW, Yu SH, et al. Improved glycemic control without hypoglycemia in elderly diabetic patients using the ubiquitous healthcare service, a new medical information system. Diabetes Care 2011;34(2):308‐13. [DOI: 10.2337/dc10-1447] - DOI - PMC - PubMed
McKinstry 2013
    1. McKinstry B, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, et al. Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial. BMJ 2013;346:f3030. [DOI: ] - PMC - PubMed
Michie 2015
    1. Michie S, Wood CE, Johnston M, Abraham C, Francis JJ, Hardeman W. Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data). Health Technology Assessment 2015;19(99):1‐187. - PMC - PubMed
Naderi 2012
    1. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta‐analysis on 376,162 patients. American Journal of Medicine 2012;125(9):882‐7. - PubMed
Naghavi 2017
    1. Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd‐Allah F, Abera SF, et al. Global, regional, and national age‐sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390(10100):1151‐210. [DOI: ] - PMC - PubMed
Nieuwlaat 2014
    1. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD000011.pub4] - DOI - PMC - PubMed
Orrell 2015
    1. Orrell C, Cohen K, Mauff K, Bangsberg DR, Maartens G, Wood R. A randomized controlled trial of real‐time electronic adherence monitoring with text message dosing reminders in people starting first‐line antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 2015;69(15):551‐9. [DOI: 10.1097/QAI.0000000000000651] - DOI - PubMed
Park 2014a
    1. Park LG, Howie‐Esquivel J, Chung ML, Dracup K. A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counselling 2014;94(2):261‐8. - PubMed
Park 2014b
    1. Park LG, Howie‐Esquivel J, Dracup K. A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence. Journal of Advanced Nursing 2014;70(9):1932‐53. - PubMed
Piepoli 2016
    1. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Journal of Preventive Cardiology 2016;23(11):NP1‐96. - PubMed
Piette 2012
    1. Piette JD, Datwani H, Gaudioso S, Foster SM, Westphal J, Perry W, et al. Hypertension management using mobile technology and home blood pressure monitoring: results of a randomized trial in two low/middle‐income countries. Telemedicine and e‐Health 2012;18(8):613‐20. - PMC - PubMed
Pop‐Eleches 2011
    1. Pop‐Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource‐limited setting: a randomized controlled trial of text message reminders. AIDS 2011;25(6):825‐34. [DOI: 10.1097/QAD.0b013e32834380c1] - DOI - PMC - PubMed
Pound 2005
    1. Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker‐White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Social Science and Medicine 2005;61(1):133‐55. [DOI: 10.1016/j.socscimed.2004.11.063] - DOI - PubMed
Review Manager 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rugge 2011
    1. Rugge B, Balshem H, Sehgal H, Relevo R, Gorman P, Helfand M. Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism. Rockville (MD): Agency for Healthcare Research and Quality, 2011. - PubMed
Sabin 2015
    1. Sabin LL, Bachman DeSilva M, Gill CJ, Zhong L, Vian T, Xie W, et al. Improving adherence to antiretroviral therapy with triggered real‐time text message reminders: the China Adherence Through Technology Study. Journal of Acquired Immune Deficiency Syndromes 2015;69(5):551‐9. [EMBASE: 10.1097/QAI.0000000000000651] - PMC - PubMed
Smith 2015
    1. Smith C, Ngo TD, Gold J, Edwards P, Vannak U, Sokhey L, et al. Effect of a mobile phone‐based intervention on post‐abortion contraception: a randomized controlled trial in Cambodia. Bulletin of the World Health Organization 2015;93(12):842‐50A. - PMC - PubMed
USPSTF 2014
    1. US Preventive Services Task Force. The guide to clinical preventive services: recommendations of the U.S. Preventive Services Task Force, 2014. www.uspreventiveservicestaskforce.org/Page/Name/tools‐and‐resources‐for‐... (accessed 11 April 2017).
Vermeire 2001
    1. Vermeire E, Hearnshaw H, Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics 2001;26(5):331‐42. - PubMed
Vinogradova 2016
    1. Vinogradova Y, Coupland C, Brindle P, Hippisley‐Cox J. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database. BMJ 2016;353:i3305. [DOI: ] - PMC - PubMed
WHO 2003
    1. World Health Organization. Adherence to long‐term therapies: evidence for action, 2003. www.who.int/chp/knowledge/publications/adherence_report/en/ (accessed 15 February 2017).
WHO 2007
    1. World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk, 2007. www.who.int/cardiovascular_diseases/publications/Prevention_of_Cardiovas... (accessed 15 February 2017).
WHO 2011
    1. World Health Organization. Global Atlas on Cardiovascular Disease Prevention and Control, 2011. www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/ (accessed 15 February 2017).
WHO 2016
    1. World Health Organization. Cardiovascular diseases (CVDs) fact sheet N° 317, 2016. www.who.int/mediacentre/factsheets/fs317/en/ (accessed 24 May 2017).
World Bank 2017
    1. World Bank. World Development Indicators 2017. Washington, DC: World Bank. License: Creative Commons Attribution CC BY 3.0 IGO. openknowledge.worldbank.org/handle/10986/26447 (accessed 30 May 2017).
Yoo 2009
    1. Yoo HJ, Park MS, Kim TN, Yang SJ, Cho GJ, Hwang TG, et al. A Ubiquitous Chronic Disease Care system using cellular phones and the internet. Diabetic Medicine 2009;26(6):628‐35. [DOI: 10.1111/j.1464-5491.2009.02732.x.] - DOI - PubMed

References to other published versions of this review

Palmer 2017
    1. Palmer MJ, Barnard S, Perel P, Free C. Mobile phone‐based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database of Systematic Reviews 2017, Issue 5. [DOI: 10.1002/14651858.CD012675] - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources